Jan Nils Sandström
Directeur Général chez JNS Consulting AB
Profil
Jan Nils Sandström is currently the Chairman & Chief Executive Officer at JNS Consulting AB since 2013.
He is also a Non-Executive Director at Eurocine Vaccines AB since 2012 and a Director at Gripping Heart AB.
Formerly, Mr. Sandström held positions such as Chairman at NovaSAID AB and TikoMed AB.
He was also the Chairman at Nanexa AB from 2015 to 2017.
Additionally, he served as a Director at Karo Healthcare AB, Aktiespararnas Service AB, Accelerator Nordic AB, Independent Pharmaceutica AB, Sveriges Aktiesparares Riksförbund, Betagenon Sweden AB, Karobio AB, Sarf Service AB, and Riksförbundet Sveriges Lottakårer Ideell förening.
Mr. Sandström has also worked at AstraZeneca AB as a Senior Vice President-Business Development & VP, Biolipox AB as SVP-Business Development & Licensing, Astra Pharmaceuticals AB as Senior Vice President-Business Development & VP, Egetis Therapeutics AB as Senior VP-Business Development & Licensing from 2010 to 2011, and Astra Pain Control AB as VP-Business Development & Licensing.
Postes actifs de Jan Nils Sandström
| Sociétés | Poste | Début |
|---|---|---|
| Gripping Heart AB | Directeur/Membre du Conseil | 06/07/2012 |
| JNS Consulting AB | Directeur Général | 08/01/2013 |
Anciens postes connus de Jan Nils Sandström
| Sociétés | Poste | Fin |
|---|---|---|
| Riksförbundet Sveriges Lottakårer Ideell förening | Directeur/Membre du Conseil | - |
| Sarf Service AB | Directeur/Membre du Conseil | - |
Betagenon Sweden AB
 Betagenon Sweden AB Pharmaceuticals: MajorHealth Technology Betagenon AB engages in development of AMP-activated protein kinase (AMPK) activator compounds chronic energy balance disorders diseases. The company was founded by Helena Edlund, Thomas Edlund and Olof Karlsson and is headquartered in Umea, Sweden. | Directeur/Membre du Conseil | - |
| NANEXA AB | Président | 01/01/2017 |
| Karobio AB | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| KARO PHARMA AB (PUBL) | Health Technology |
| EGETIS THERAPEUTICS AB | Health Technology |
| NANEXA AB | Health Technology |
| Entreprise privées | 17 |
|---|---|
Eurocine Vaccines AB
 Eurocine Vaccines AB Pharmaceuticals: MajorHealth Technology Eurocine Vaccines AB engages in the research and development of nasal influenza vaccine for children and adult. Its technology, Endocine used to develop a patent protected nasal influenza vaccine for children. The company was founded in 1999 and is headquartered in Solna, Sweden. | Health Technology |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
Aktiespararnas Service AB
 Aktiespararnas Service AB Miscellaneous Commercial ServicesCommercial Services Aktiespararnas Service AB is a membership organization that provides tools and resources for individuals interested in investing in stocks and funds. The Swedish company's platform, Hitta kursvinnare, offers modules such as Urval/Sök, Bolag, Nyckeltalssorteraren, Kurslista, Ranking, and Signaler to help users make informed decisions about stock trading. The organization aims to defend the interests of small investors and provides independent knowledge and objective financial advice. The private company offers guidance and inspiration to help individuals achieve their savings goals, regardless of their level of experience. | Commercial Services |
Biolipox AB
 Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | Health Technology |
Accelerator Nordic AB
 Accelerator Nordic AB Pharmaceuticals: MajorHealth Technology Accelator Nordic AB, a holding company, is engaged in the field of life science. It focuses on the development of image software and medical nanotechnology. It operates through its subsidiaries SPAGO Imaging AB, Synthethic MR AB, and PledPharma. The company was founded in March 1993 and is headquartered in Stockholm, Sweden. | Health Technology |
| Astra Pharmaceuticals AB | |
Independent Pharmaceutica AB
 Independent Pharmaceutica AB Medical DistributorsDistribution Services Independent Pharmaceutica AB is a privately owned company. The major owners are Karolinska Investment Fund, LH Advisory, Sandin &Co and The Foundation for Baltic and East European Studies (Östersjöstiftelsen). Independent Pharmaceutica aims to provide pharmacological solutions for treatment of nicotine addiction. The company is spun out of research from the Karolinska Institutet in Stockholm, Sweden. Tobacco use is the leading preventable cause of morbidity and premature death in the world.Currently over 1.2 billion people smoke worldwide and the number of annual deaths from tobacco-related diseases is over 4 million and rising. The costs for society are huge. With the new vaccine Niccine® against nicotine addiction, the health condition of millions of patients is expected to be improved. | Distribution Services |
| Gripping Heart AB | |
NovaSAID AB
 NovaSAID AB Pharmaceuticals: MajorHealth Technology NovaSAID AB develops treatments for inflammation and pain in conditions such as rheumatoid arthritis. It discovers selective microsomal prostaglandin E synthase-1 (mPGES-1), and has also demonstrated its effect in animal models for pain and inflammation. The firm's approach is to prevent the pathological formation of prostaglandin E2 (PGE2) selectively, through the development of inhibitors of mPGES-1, the enzyme that is responsible for the formation of PGE2 during inflammation. Its mPGES-1 inhibition offers an approach for inhibiting pathological PGE2 production without adversely affecting other important prostanoids. The company was founded by Per-Johan Göte Jakobsson, Ralf Morgenstern, Bertil Samuelsson and Bengt Ingemar Samuelsson on October 26, 2004 and is headquartered in Solna, Sweden. | Health Technology |
TikoMed AB
 TikoMed AB Pharmaceuticals: MajorHealth Technology TikoMed AB is a Swedish pharmaceutical company that develops pharmaceutical products. The private company is based in Viken, Sweden. The company was founded by Adam Bruce, Lars Bruce. Anders Kristensson has been the CEO of the company since 2018. | Health Technology |
Sveriges Aktiesparares Riksförbund
 Sveriges Aktiesparares Riksförbund Miscellaneous Commercial ServicesCommercial Services Sveriges Aktiesparares Riksförbund is an organization working in the interests of private individuals who invest in stocks, mutual funds, and other stock related securities. It offers information and education, stock trading services, and small shareholder rights plan. The company was founded on February 5, 1966 and is headquartered in Stockholm, Sweden. | Commercial Services |
| JNS Consulting AB | |
Betagenon Sweden AB
Betagenon Sweden AB Pharmaceuticals: MajorHealth Technology Betagenon AB engages in development of AMP-activated protein kinase (AMPK) activator compounds chronic energy balance disorders diseases. The company was founded by Helena Edlund, Thomas Edlund and Olof Karlsson and is headquartered in Umea, Sweden. | Health Technology |
| Karobio AB | |
| Astra Pain Control AB | |
| Sarf Service AB | |
| Riksförbundet Sveriges Lottakårer Ideell förening |
